AMP German Cannabis Group Inc. announced the appointment of Mr. Marc Wälken as Sales Director, effective immediately. Mr. Wälken joins AMP from Spectrum Therapeutics, a brand of Canopy Growth Germany GmbH, a wholly-owned subsidiary of Canopy Growth Corporation, where he was Areas Sales Manager and Key Account Manager. Prior to that, Mr. Wälken was a sales representative for Roche Pharma AG, the German division of The Roche Group. Mr. Wälken is responsible for implementing and managing sales strategies to introduce AMP's branded cannabis products and build AMP's national sales team. The development of a national sales team is important in generating strong revenue growth.